Differential Effects of Albumin Infusion between ICU and Non-ICU Hypoalbuminemia Patients

Authors

  • Nina Mariana RSPI Sulianti Saroso
  • Surya Oto Wijaya
  • Rumaisah Setyawati
  • Siti Maemun
  • Nafrialdi Nafrialdi

DOI:

https://doi.org/10.21776/ub.pji.2021.007.01.3

Keywords:

hypoalbuminemia, albumin, intensive care unit, sepsis

Abstract

Background: Hypoalbuminemia is frequent among hospitalized patients and is associated with poor outcomes. ICU patients are widely associated with more severe condition making albumin correction seems to be less effective. This study was aimed to compare the results of albumin correction in ICU and non-ICU patients at Sulianti Saroso Hospital, Jakarta.

 

Methods: A cross sectional study was conducted on adult patients in ICU and non-ICU wards who received intravenous albumin infusion at Sulianti Saroso hospital, between January 2013 to March 2018. Paired t-test was used to analyze the changes of albumin level before and after albumin infusion.

 

Results: 123 ICU patients (41 sepsis, 82 non-sepsis) and 206 non-ICU patients (34 sepsis, 172 non-sepsis) who received 20% or 25% albumin infusions were included. Significant increase in albumin levels were observed in sepsis patients both in ICU and non-ICU, while in non-sepsis patients, the significant increase only observed in non-sepsis patients. Overall, mean increase in albumin levels in ICU-and non-ICU patients were 0.13 (0.63) g/dL vs 0.35(0.54) g/dL, respectively (P= < 0,001).

 

Conclusion: Non-ICU patients show better response to albumin infusion compared to ICU patients. This difference is presumably due to different degree of inflammation. It is suggested that the quantity needed for albumin infusion is calculated differently according to clinical condition of the patients

 

 

 

Author Biography

  • Nina Mariana, RSPI Sulianti Saroso
    Research Instalation

References

. Caraceni P, Domenicali M, Tovoli A, Napoli L, Serena Ricci C, Tufoni M, Bernardi M. Clinical indications for the albumin use: Still a controversial issue. Eur J Intern Med2013;24:721–8. doi: 10.1016/j.ejim.2013.05.015. Epub 2013 Jun 20.

. Giancarlo L, Francesco B, Gina R. Recommendations for the use of albumin and immunoglobulin. Blood transfus 2009.27:216-234.doi: 10.2450/2009.0094-09

.Cheng HC, Yang EH, Wu CT, Wang WL, Chen PJ, Lin MY, et al . Hypoalbuminemia is predictor of mortality and rebleeding in peptic ulcer bleeding under proton pump inhibitor use. JFormosMed Assoc2018;117:316-25. doi: 10.1016/j.jfma.2017.07.006. Epub 2017 Jul 24

. Mi Yeon, Sung WL, Seon HB, Ki young, Dong WC, Ho jun, Sejoong K. Hypoalbuminnemia at admission predicts the development of acute kidney injury in hospitalized patients: A retrospective cohort study. PLoS One. 2017 Jul 19;12(7): e0180750. doi: 10.1371/journal.pone.0180750. eCollection 2017.

. Zusman O, Farbman L, Tredler Z, Daitch V, Leibovici A. Paul M. Association between hypoalbuminemia and mortality among subjects treated with ertapenem versus other carbapenems: prospective cohort study. Clin Microbiol Infect. 2015 Jan;21(1):54-8. doi: 10.1016/j.cmi.2014.08.003. Epub 2014 Oct 12.

.Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2013;28(2):CD000567.doi:0.1002/14651858.CD000567.pub6. Available at https://www.ncbi.nlm.nih.gov/pubmed/23450531 [accessed Feb 25, 2020].

.Benefit L, Benefit M.Guidelines for Intravenous Albumin Administration at Stanford Health Care Policy. Stanford Health Care Pharmacy Department. Created: 03/2017

. Jellinge ME, Henriksen DP, Hallas P, Brabrand M. Hypoalbuminemia is a strong predictor of 30-day allcause mortality in admitted medical patients: a prospective, observational, cohort study. PlosOne 2014,9:e105983. doi: 10.1371/journal.pone.0105983

.Caironi P,Tognoni G, Masson S,Fumagalli R,Pesenti A, Romero M et al.Albumin replacement in patients with severe sepsis or septic shock.N Engl J Med.2014;370(15):1412-21.doi: 10.1056/NEJMoa1305727. Epub 2014 Mar 18.

. Behzad M, Seyed H, Amin A. A model for decision making for intensive care unit admission source limited hospitals. Iran Red Crescent Med J. 2014;16(10):e15497.

. Arafuri N, WidjajantoPH, Haksari EL. Risk factors for the failure to achieve normal albumin serum levels after albumin transfusions in neonates. Paediatr Indones.2016; 56:129-33

.Quinlan GJ, Margason MP, Muraby S, Evans TW, Gutteridge JM. Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci (Lond) 1998; 95 (4): 459-65.

. Falco H, Japiassu AM. Albumin in critically ill patients: controversies and recommendations. Rev Bras Ter Intensiva.2011: 23:87-95

. Mitra S, Khandelwal P. Are all colloids same? How to select the right colloids? Indian J Anesth. 2009;53(5):592-607.

. Jiang L, Jiang S, Mao Zhang M, Zheng Z, Ma Y. Albumin versus Other Fluids for FluidResuscitation in Patients with Sepsis: AMeta-Analysis. PLoS ONE 9(12): e114666. doi:10.1371/journal.pone.0114666: 2014.

. Alderson P, Bunn F, Li WP, Pearson M, Robert J, Schierhout G. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2011;9: CD001208. doi: 10.1002/14651858.CD001208.pub4

. Delaney AP, Dan A, McCaffrey J, Finfer S. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and metaanalysis. Crit Care Med.2011;39:386-91. doi: 10.1097/CCM.0b013e3181ffe217.

Downloads

Published

2021-12-30

Issue

Vol. 7 No. 1 (2021)

Section

Articles

License

Copyright (c) 2021 Pharmaceutical Journal of Indonesia Creative Commons Licence
This work is licensed under a Creative Commons Attribution 4.0 International License